Aurora Spine Achieves Milestone with DEXA-C

Aurora Spine’s DEXA-C system has now been successfully used in more than 1,500 cervical spine procedures across the United States. This milestone underscores the ongoing adoption of the DEXA Technology platform.

Aurora’s proprietary DEXA Technology is the world’s first spinal implant platform intentionally engineered to match a patient’s bone density across the entire BMD continuum, including normal, osteopenic and osteoporotic bone. Each implant is designed with an open, porous structure that promotes osseointegration and vascularization, and mimics the lattice architecture of human cancellous bone — resulting in a similar modulus of elasticity and better biomechanical compatibility.

Aurora Spine is excited to announce the upcoming Q4 2025 launch of DEXA-L, a standalone Anterior Lumbar Interbody Fusion (ALIF) system. Like DEXA-C, the DEXA-L implant is designed to address the challenges of spinal fusion in patients with varying bone densities — especially those with osteoporosis.

For decades, spinal implants were primarily developed for patients with healthy bone stock. However, these implants have demonstrated reduced performance in patients with low bone density, where traditional designs may lack sufficient bone-implant contact and fail to achieve long-term fixation. DEXA Technology directly addresses this clinical gap, offering a density-matched solution for today’s diverse patient population.

“DEXA-C provides surgeons with the first tool that truly puts bone quality at the center of implant selection,” said Trent Northcutt, President and CEO of Aurora Spine. “With over 1,500 successful surgeries behind us, the data is clear: this technology improves outcomes. And now, we’re ready to take it even further as we build out our sales efforts for this platform technology and prepare launch for our second DEXA Technology-enabled product the DEXA-L, which will be rolled out later this year.”

Source: Aurora Spine